Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2010) |  Total Docs. (3years) |
Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Pharmacological Research | journal | 1.479 Q1 | 169 | 133 | 372 | 8179 | 1762 | 359 | 4.09 | 61.50 |  |
| 52 | Therapeutic Innovation and Regulatory Science | journal | 0.100 Q4 | 51 | 136 | 366 | 2348 | 149 | 351 | 0.31 | 17.26 | |
| 53 | BioPharm International | trade journal | 0.288 Q2 | 32 | 99 | 361 | 657 | 120 | 312 | 0.36 | 6.64 | |
| 54 | Human and Experimental Toxicology | journal | 0.465 Q3 | 91 | 124 | 353 | 3906 | 563 | 327 | 1.30 | 31.50 | |
| 55 | Reproductive Toxicology | journal | 1.334 Q1 | 129 | 137 | 348 | 6145 | 1524 | 328 | 3.41 | 44.85 | |
| 56 | Pharmacogenetics and Genomics | journal | 1.479 | 152 | 96 | 347 | 4069 | 1634 | 342 | 4.31 | 42.39 | |
| 57 | Toxicologic Pathology | journal | 0.915 Q2 | 124 | 116 | 346 | 4556 | 932 | 322 | 2.18 | 39.28 | |
| 58 | Journal of Gene Medicine | journal | 0.991 Q1 | 100 | 98 | 334 | 3755 | 1128 | 329 | 3.16 | 38.32 | |
| 59 | Therapeutic Drug Monitoring | journal | 0.887 Q2 | 102 | 129 | 333 | 4198 | 1070 | 325 | 3.42 | 32.54 | |
| 60 | Journal of Studies on Alcohol and Drugs | journal | 1.309 Q1 | 137 | 114 | 330 | 4541 | 879 | 329 | 2.26 | 39.83 | |
| 61 | Pharmaceutical Technology Europe | journal | 0.140 Q3 | 19 | 144 | 330 | 429 | 40 | 269 | 0.12 | 2.98 | |
| 62 | Journal of Analytical Toxicology | journal | 0.761 Q2 | 85 | 90 | 325 | 2289 | 549 | 300 | 1.50 | 25.43 | |
| 63 | Journal of managed care & specialty pharmacy | journal | 1.087 Q1 | 75 | 65 | 324 | 1766 | 668 | 208 | 1.90 | 27.17 | |
| 64 | Journal of Biomolecular Screening | journal | 1.017 Q1 | 86 | 132 | 320 | 3470 | 864 | 318 | 2.80 | 26.29 | |
| 65 | Pharmacology and Therapeutics | journal | 3.872 Q1 | 233 | 103 | 307 | 22992 | 3285 | 304 | 9.97 | 223.22 | |
| 66 | Bulletin of Mathematical Biology | journal | 0.940 Q2 | 97 | 88 | 306 | 3386 | 645 | 305 | 2.09 | 38.48 | |
| 67 | American Journal of Therapeutics | journal | 0.625 Q2 | 69 | 118 | 303 | 4084 | 487 | 279 | 1.56 | 34.61 | |
| 68 | American Pharmaceutical Review | journal | 0.238 Q2 | 26 | 86 | 301 | 1240 | 118 | 301 | 0.44 | 14.42 | |
| 69 | Human Vaccines | journal | 0.857 Q1 | 63 | 184 | 283 | 7231 | 594 | 228 | 2.17 | 39.30 | |
| 70 | Journal of Immunotherapy | journal | 1.784 Q1 | 106 | 99 | 283 | 4322 | 1122 | 281 | 3.79 | 43.66 | |
| 71 | Assay and Drug Development Technologies | journal | 0.966 Q2 | 65 | 119 | 271 | 1960 | 426 | 144 | 1.48 | 16.47 | |
| 72 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.668 Q2 | 68 | 93 | 266 | 2971 | 497 | 260 | 2.21 | 31.95 | |
| 73 | Behavioural Pharmacology | journal | 1.359 Q1 | 87 | 81 | 250 | 5428 | 726 | 247 | 2.65 | 67.01 | |
| 74 | Journal of Biopharmaceutical Statistics | journal | 1.064 Q1 | 56 | 85 | 246 | 1783 | 354 | 224 | 1.13 | 20.98 | |
| 75 | Reading Teacher | journal | 0.721 Q2 | 60 | 85 | 244 | 1516 | 208 | 242 | 0.83 | 17.84 | |
| 76 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.718 Q2 | 72 | 94 | 241 | 2599 | 518 | 232 | 2.08 | 27.65 | |
| 77 | Vascular Pharmacology | journal | 0.827 Q2 | 108 | 68 | 239 | 3663 | 616 | 237 | 2.36 | 53.87 | |
| 78 | Environmental Toxicology | journal | 0.769 Q2 | 90 | 71 | 238 | 2945 | 485 | 238 | 1.88 | 41.48 | |
| 79 | Medical Letter on Drugs and Therapeutics | journal | 0.185 Q3 | 22 | 117 | 232 | 441 | 82 | 225 | 0.35 | 3.77 | |
| 80 | Biotechnology and Applied Biochemistry | journal | 0.594 Q2 | 81 | 60 | 231 | 2377 | 456 | 230 | 1.83 | 39.62 | |
| 81 | Current Cardiovascular Risk Reports | journal | 0.210 Q3 | 34 | 65 | 221 | 2782 | 63 | 213 | 0.32 | 42.80 | |
| 82 | Clinical Neuropharmacology | journal | 0.634 Q2 | 85 | 78 | 214 | 1991 | 493 | 184 | 1.83 | 25.53 | |
| 83 | Pharmaceutical Development and Technology | journal | 0.612 Q1 | 70 | 74 | 204 | 2198 | 272 | 201 | 1.07 | 29.70 | |
| 84 | PPAR Research | journal | 1.176 Q1 | 59 | 59 | 196 | 4684 | 539 | 183 | 2.56 | 79.39 | |
| 85 | Alcohol | journal | 0.819 Q2 | 88 | 74 | 195 | 4078 | 498 | 191 | 2.60 | 55.11 | |
| 86 | Journal of Biomedical Nanotechnology | journal | 0.573 Q1 | 93 | 78 | 195 | 3787 | 533 | 188 | 2.74 | 48.55 | |
| 87 | AAPS Journal | journal | 1.494 Q1 | 132 | 82 | 189 | 3723 | 983 | 185 | 4.10 | 45.40 | |
| 88 | International Journal of Toxicology | journal | 0.551 Q3 | 71 | 74 | 189 | 3630 | 349 | 184 | 1.65 | 49.05 | |
| 89 | Journal of Pharmacological and Toxicological Methods | journal | 0.664 Q2 | 83 | 76 | 189 | 2902 | 474 | 185 | 2.58 | 38.18 | |
| 90 | Biologicals | journal | 0.602 Q2 | 66 | 113 | 181 | 3214 | 329 | 167 | 1.89 | 28.44 | |
| 91 | Neurotoxicity Research | journal | 1.130 Q1 | 84 | 69 | 179 | 3720 | 517 | 175 | 2.86 | 53.91 | |
| 92 | Drug Development Research | journal | 0.374 Q3 | 67 | 55 | 172 | 2134 | 190 | 156 | 1.15 | 38.80 | |
| 93 | Medicinal Chemistry Research | journal | 0.366 Q1 | 59 | 104 | 172 | 2637 | 215 | 172 | 1.04 | 25.36 | |
| 94 | Prostaglandins and Other Lipid Mediators | journal | 1.146 Q1 | 86 | 49 | 169 | 2791 | 471 | 166 | 2.26 | 56.96 | |
| 95 | Experimental and Clinical Psychopharmacology | journal | 1.313 Q1 | 101 | 58 | 165 | 3134 | 524 | 165 | 2.87 | 54.03 | |
| 96 | Neurotoxicology and Teratology | journal | 0.995 Q2 | 111 | 76 | 158 | 4273 | 506 | 156 | 2.86 | 56.22 | |
| 97 | Pharmaceutical Engineering | journal | 0.177 Q3 | 18 | 41 | 153 | 249 | 21 | 137 | 0.12 | 6.07 | |
| 98 | BioProcess International | trade journal | 0.319 Q3 | 26 | 141 | 150 | 737 | 51 | 147 | 0.34 | 5.23 | |
| 99 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.409 Q2 | 43 | 72 | 149 | 1227 | 124 | 141 | 0.68 | 17.04 | |
| 100 | Journal of Medical Toxicology | journal | 0.615 Q2 | 58 | 97 | 148 | 1859 | 212 | 126 | 1.39 | 19.16 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data